Eli Lilly Seeks Approval for New Obesity Drug

Eli Lilly is moving forward with a new drug called retatrutide. This medicine helps people with obesity. The company will ask for government approval by 2027.

Retatrutide has shown good results in five trials. These trials are the final steps before a drug can get approval. The drug helps people lose weight. It might become a key part of Lilly's efforts to fight obesity.

More and more people face challenges with their weight. New drugs offer hope. Eli Lilly's work could provide a fresh option for better health. This new medicine helps the body manage weight.

Source: CNBC